)
Psychemedics (PMD) investor relations material
Psychemedics Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Psychemedics Corporation specializes in patented hair-based drug testing, serving corporate, school, and government clients in the US and internationally.
2024 revenue declined 11% year-over-year to $19.7 million, mainly due to lower domestic testing volumes.
The company completed a reverse/forward stock split and delisted from Nasdaq, now trading on the OTC Pink Market.
Management believes current liquidity is sufficient for at least 12 months, but no fixed credit lines remain.
Financial highlights
Revenue: $19.7M in 2024, down from $22.1M in 2023 (-11%); US revenue fell 12%, international rose 22%.
Net loss: $(1.9)M in 2024, improved from $(4.2)M in 2023.
Gross profit: $7.1M in 2024, down 16% year-over-year.
Operating loss: $(1.9)M in 2024, improved from $(2.9)M in 2023.
Cash at year-end: $1.4M (down from $2.0M); positive operating cash flow of $929K in 2024.
Outlook and guidance
Management expects current cash and future operating profits to cover working capital and capital expenditures for at least the next year.
No formal revenue or earnings guidance provided; future growth depends on customer acquisition and market conditions.
- Approval sought for stock split, buyout, and delisting to go private and reduce costs.PMD
Proxy Filing - Approval sought for going-private transaction, cashing out small holders and delisting shares.PMD
Proxy Filing - Proposals seek approval for delisting, deregistration, and cashing out small shareholders at $2.35 per share.PMD
Proxy Filing - Stockholders to vote on going-private plan, cashing out small holders and delisting from Nasdaq.PMD
Proxy Filing - Reverse split, delisting, and private placement to cut costs and cash out small holders, pending vote.PMD
Proxy Filing - Adjournment Proposal is routine; brokers may vote at their discretion, with no broker non-votes.PMD
Proxy Filing - Q3 2024 revenue fell 9% as net loss narrowed and delisting plans advanced.PMD
Q3 2024 - Q2 2024 revenue fell 15% and net loss widened as delisting aims to cut costs.PMD
Q2 2024
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)